Agreement to Supply Europe with COVID-19 Vaccine
13 June 2020 14:00 BST AstraZeneca to supply Europe with up to 400 million doses of Oxford University's vaccine at no profit Company exploring further additional global capacity to provide broad and equitable access AstraZeneca has reached an agreement with Europe's Inclusive Vaccines Alliance (IVA), spearheaded by Germany, France, Italy and the Netherlands, to supply up to 400 million doses of the University of Oxford's COVID-19 vaccine, with deliveries starting by the end of 2020. With today's agreement, the IVA aims to accelerate the supply of the vaccine and to make it